Researchers presented new findings Saturday at a breast-cancer symposium here suggesting that the risks associated with anthracyclines, a class of chemotherapy drugs widely used to treat the disease, outweighed their benefits in some patients.The findings renewed a debate over whether anthracyclines, which have been around since the 1960s, should remain the standard of care in treating breast cancer, or whether newer drugs should be used more frequently instead.
More...
		
 Health Glance
Imagine being watched by two undercover cops as you engage in an illicit deal in a deserted parking lot. The buyer hesitantly hands you some cash. You flash a look over your shoulder, just to make sure the coast is clear, then you hand over the contraband. Neither of you says a word. You just nod, acknowledging the deal is done, then you head back to your car and buckle up for the drive home.
In fact, a new study just presented at the annual meeting of the Radiological Society of North America (RSNA), concludes the low-dose radiation from annual mammography screening significantly increases breast cancer risk in women with a genetic or familial predisposition to breast cancer. This is particularly worrisome because women who are at high risk for breast cancer are regularly pushed to start mammograms at a younger age -- as early as 25 -- and that means they are exposed to more radiation from mammography earlier and for more years than women who don't have breast cancer in their family trees.





























